Cargando…

Ampicillin Silver Nanoformulations against Multidrug resistant bacteria

The present study reported a single step synthesis of silver nanoparticles using ampicillin (Amp-AgNps), a second-generation β lactam antibiotic to get nanoformulation having dual properties that of antibiotic and silver. The Amp-AgNps was characterized by UV-VIS spectroscopy, TEM, XRD, FTIR and TGA...

Descripción completa

Detalles Bibliográficos
Autores principales: Khatoon, Nafeesa, Alam, Hammad, Khan, Afreen, Raza, Khalid, Sardar, Meryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497658/
https://www.ncbi.nlm.nih.gov/pubmed/31048721
http://dx.doi.org/10.1038/s41598-019-43309-0
_version_ 1783415503470985216
author Khatoon, Nafeesa
Alam, Hammad
Khan, Afreen
Raza, Khalid
Sardar, Meryam
author_facet Khatoon, Nafeesa
Alam, Hammad
Khan, Afreen
Raza, Khalid
Sardar, Meryam
author_sort Khatoon, Nafeesa
collection PubMed
description The present study reported a single step synthesis of silver nanoparticles using ampicillin (Amp-AgNps), a second-generation β lactam antibiotic to get nanoformulation having dual properties that of antibiotic and silver. The Amp-AgNps was characterized by UV-VIS spectroscopy, TEM, XRD, FTIR and TGA. FTIR and TGA results suggested that amine group of Ampicllin reduce the metalic silver into nano form. These results were further validated by computational molecular dynamics simulation. The antibacterial potential of Amp-AgNps was investigated against sensitive and drug resistant bacteria. MIC of Amp-AgNps against 6 different bacterial strains were in the range of 3–28 µg/ml which is much lower than the MIC of ampicillin (12–720 µg/ml) and chemically synthesized silver nanoparticles (280–640 µg/ml). The repeated exposure to drugs may lead to development of resistance mechanism in bacteria against that drug, so the efficacy of Amp-AgNps after repeated exposure to bacterial strains were also studied. The results indicate that bacterial strains do not show any resistance to these Amp-AgNps even after exposure up to 15 successive cycles. The biocompatibility of these Amp-AgNps was checked against cell lines by using Keratinocytes cell lines (HaCaT).
format Online
Article
Text
id pubmed-6497658
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64976582019-05-17 Ampicillin Silver Nanoformulations against Multidrug resistant bacteria Khatoon, Nafeesa Alam, Hammad Khan, Afreen Raza, Khalid Sardar, Meryam Sci Rep Article The present study reported a single step synthesis of silver nanoparticles using ampicillin (Amp-AgNps), a second-generation β lactam antibiotic to get nanoformulation having dual properties that of antibiotic and silver. The Amp-AgNps was characterized by UV-VIS spectroscopy, TEM, XRD, FTIR and TGA. FTIR and TGA results suggested that amine group of Ampicllin reduce the metalic silver into nano form. These results were further validated by computational molecular dynamics simulation. The antibacterial potential of Amp-AgNps was investigated against sensitive and drug resistant bacteria. MIC of Amp-AgNps against 6 different bacterial strains were in the range of 3–28 µg/ml which is much lower than the MIC of ampicillin (12–720 µg/ml) and chemically synthesized silver nanoparticles (280–640 µg/ml). The repeated exposure to drugs may lead to development of resistance mechanism in bacteria against that drug, so the efficacy of Amp-AgNps after repeated exposure to bacterial strains were also studied. The results indicate that bacterial strains do not show any resistance to these Amp-AgNps even after exposure up to 15 successive cycles. The biocompatibility of these Amp-AgNps was checked against cell lines by using Keratinocytes cell lines (HaCaT). Nature Publishing Group UK 2019-05-02 /pmc/articles/PMC6497658/ /pubmed/31048721 http://dx.doi.org/10.1038/s41598-019-43309-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Khatoon, Nafeesa
Alam, Hammad
Khan, Afreen
Raza, Khalid
Sardar, Meryam
Ampicillin Silver Nanoformulations against Multidrug resistant bacteria
title Ampicillin Silver Nanoformulations against Multidrug resistant bacteria
title_full Ampicillin Silver Nanoformulations against Multidrug resistant bacteria
title_fullStr Ampicillin Silver Nanoformulations against Multidrug resistant bacteria
title_full_unstemmed Ampicillin Silver Nanoformulations against Multidrug resistant bacteria
title_short Ampicillin Silver Nanoformulations against Multidrug resistant bacteria
title_sort ampicillin silver nanoformulations against multidrug resistant bacteria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497658/
https://www.ncbi.nlm.nih.gov/pubmed/31048721
http://dx.doi.org/10.1038/s41598-019-43309-0
work_keys_str_mv AT khatoonnafeesa ampicillinsilvernanoformulationsagainstmultidrugresistantbacteria
AT alamhammad ampicillinsilvernanoformulationsagainstmultidrugresistantbacteria
AT khanafreen ampicillinsilvernanoformulationsagainstmultidrugresistantbacteria
AT razakhalid ampicillinsilvernanoformulationsagainstmultidrugresistantbacteria
AT sardarmeryam ampicillinsilvernanoformulationsagainstmultidrugresistantbacteria